These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9682353)

  • 21. A placebo-controlled trial of a pertussis-toxoid vaccine.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
    N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
    CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global DTP manufacturing capacity and capability. Status report: January 1995.
    Milstien JB; Gellin BG; Kane M; di Fabio JL; Homma A
    Vaccine; 1996 Mar; 14(4):313-20. PubMed ID: 8744559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey.
    Hoppenbrouwers K; Kanra G; Roelants M; Ceyhan M; Vandermeulen C; Yurdakök K; Silier T; Dupuy M; Pehlivan T; Ozmert E; Desmyter J
    Vaccine; 1999 Feb; 17(7-8):875-86. PubMed ID: 10067694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inappropriate administration of DT/DTP vaccines.
    Nash D
    J Fam Pract; 1995 Nov; 41(5):437. PubMed ID: 7595257
    [No Abstract]   [Full Text] [Related]  

  • 27. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain.
    Baraff LJ; Manclark CR; Cherry JD; Christenson P; Marcy SM
    Pediatr Infect Dis J; 1989 Aug; 8(8):502-7. PubMed ID: 2771530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous immunization with B.C.G., diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13-14.
    Galbraith NS; Crosby G; Barnes JM; Fernandes R
    Br Med J; 1971 Apr; 2(5755):193-7. PubMed ID: 5575951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Bryla DA; Robbins JB
    J Pediatr; 1997 Apr; 130(4):532-6. PubMed ID: 9108848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating.
    Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; Redwan EM
    Hum Antibodies; 2017; 25(1-2):23-29. PubMed ID: 27858706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine.
    Baxter R; Hansen J; Timbol J; Pool V; Greenberg DP; Johnson DR; Decker MD
    Hum Vaccin Immunother; 2016 Nov; 12(11):2742-2748. PubMed ID: 27388557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial.
    Beytout J; Launay O; Guiso N; Fiquet A; Baudin M; Richard P; Baptiste C; Soubeyrand B
    Hum Vaccin; 2009 May; 5(5):315-21. PubMed ID: 19011374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants.
    Pichichero ME; Francis AB; Marsocci SM; Green JL; Disney FA
    Am J Dis Child; 1993 Mar; 147(3):295-9. PubMed ID: 8438811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
    Nakayama T; Aizawa C; Kuno-Sakai H
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):321-5. PubMed ID: 9949325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions.
    Golaz A; Hardy IR; Glushkevich TG; Areytchiuk EK; Deforest A; Strebel P; Wharton M; Sutter RW
    J Infect Dis; 2000 Feb; 181 Suppl 1():S203-7. PubMed ID: 10657215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.
    Halperin SA; Smith B; Russell M; Hasselback P; Guasparini R; Skowronski D; Meekison W; Parker R; Lavigne P; Barreto L
    Vaccine; 2000 Jan; 18(14):1312-9. PubMed ID: 10618527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can injection technique reduce vaccine reactions?
    Harris G
    Practitioner; 1983 Feb; 227(1376):299-300. PubMed ID: 6602979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.